Clinical Effects of Pulmonary Rehabilitation in Very Old Patients with COPD.
6-Minute Walk Test
FIM
elderly patients
feeling thermometer
pulmonary rehabilitation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Mar 2023
27 Mar 2023
Historique:
received:
09
03
2023
revised:
23
03
2023
accepted:
24
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Pulmonary rehabilitation (PR) improves physical and mental performance as well as quality of life in patients with chronic obstructive pulmonary disease (COPD). However, data on outcomes in very old patients are insufficient. We analyzed whether the elderly with COPD benefit in a similar way to younger patients from participation in an inpatient PR according to the assessments usually collected. Data from 3173 patients with COPD were retrospectively analyzed. Patients were referred to PR at the Zurich RehaZentren, Switzerland, between January 2013 and December 2019. PR was performed 6 days per week with an average duration of 18.85 days. Functional Independence Measurement (FIM), Feeling Thermometer (FT), and 6-Minute Walk Test (6MWT) were recorded on admission and discharge. In all age groups, the 6MWT and FT improved significantly. FIM results also showed a significant increase. The results of the different age groups showed no significant differences in percentage improvements according to the assessments that were considered. All patient groups with COPD, even the oldest (>85 years), benefited from PR regardless of their age and according to the assessments. Prospective studies are needed to support this hypothesis.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary rehabilitation (PR) improves physical and mental performance as well as quality of life in patients with chronic obstructive pulmonary disease (COPD). However, data on outcomes in very old patients are insufficient. We analyzed whether the elderly with COPD benefit in a similar way to younger patients from participation in an inpatient PR according to the assessments usually collected.
METHODS
METHODS
Data from 3173 patients with COPD were retrospectively analyzed. Patients were referred to PR at the Zurich RehaZentren, Switzerland, between January 2013 and December 2019. PR was performed 6 days per week with an average duration of 18.85 days. Functional Independence Measurement (FIM), Feeling Thermometer (FT), and 6-Minute Walk Test (6MWT) were recorded on admission and discharge.
RESULTS
RESULTS
In all age groups, the 6MWT and FT improved significantly. FIM results also showed a significant increase. The results of the different age groups showed no significant differences in percentage improvements according to the assessments that were considered.
CONCLUSIONS
CONCLUSIONS
All patient groups with COPD, even the oldest (>85 years), benefited from PR regardless of their age and according to the assessments. Prospective studies are needed to support this hypothesis.
Identifiants
pubmed: 37048597
pii: jcm12072513
doi: 10.3390/jcm12072513
pmc: PMC10095259
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur Respir Rev. 2013 Jun 1;22(128):178-86
pubmed: 23728873
Phys Ther. 2005 May;85(5):443-58
pubmed: 15842192
Ann Am Thorac Soc. 2014 May;11(4):635-44
pubmed: 24625243
Chest. 2001 Jan;119(1):70-6
pubmed: 11157586
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
J Cardiopulm Rehabil. 2003 Jan-Feb;23(1):60-8
pubmed: 12576914
Respir Med. 2004 Dec;98(12):1195-202
pubmed: 15588040
Respir Med. 2009 Aug;103(8):1224-30
pubmed: 19304473
Ann Am Thorac Soc. 2020 Oct;17(10):1213-1221
pubmed: 32644823
Prim Care Respir J. 2013 Sep;22(3):319-24
pubmed: 23797679
J Clin Epidemiol. 2003 Dec;56(12):1170-6
pubmed: 14680667
COPD. 2019 Aug;16(3-4):246-253
pubmed: 31328579
J Chronic Dis. 1985;38(6):517-24
pubmed: 4008592
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Curr Cardiol Rev. 2017;13(4):252-262
pubmed: 28699488
Pulmonology. 2019 Mar - Apr;25(2):117-118
pubmed: 30755382
J Formos Med Assoc. 2016 Aug;115(8):595-601
pubmed: 26822811
Chest. 2013 Dec;144(6):1803-1810
pubmed: 23975185
Respir Med. 2009 Mar;103(3):471-6
pubmed: 18977645
Can J Cardiol. 1999 Sep;15(9):979-85
pubmed: 10504179
Can Respir J. 2004 Sep;11(6):407-13
pubmed: 15510248
Thorax. 2001 Feb;56(2):143-5
pubmed: 11209104
Rehabil Nurs. 2014 Mar-Apr;39(2):86-93
pubmed: 23813799
Thorax. 2006 Sep;61(9):767-71
pubmed: 16449270
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Thorax. 2017 Jun;72(6):530-537
pubmed: 28077613
Mayo Clin Proc. 2002 Apr;77(4):371-83
pubmed: 11936935
Int J Nurs Pract. 2019 Oct;25(5):e12745
pubmed: 31268214
J Cardiopulm Rehabil Prev. 2015 May-Jun;35(3):207-13
pubmed: 25763921
Arch Phys Med Rehabil. 1994 Feb;75(2):127-32
pubmed: 8311667
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7
pubmed: 9817683
Clin Interv Aging. 2013;8:1489-96
pubmed: 24235821
J Bras Pneumol. 2021 Jan 08;46(6):e20200596
pubmed: 33470367
Chest. 2015 May;147(5):1316-1326
pubmed: 25742048
Chest. 2006 Dec;130(6):1704-11
pubmed: 17166985